RxDoctor Payments Data

Gennadiy Bakis, MD

Gastroenterology · Portland, ORNPI 1184614455

Payments from drug & device makers

What this record shows

5 manufacturers reported payments, led by Olympus Corporation Of The Americas at 49.6% of the total. Reporting peaked in 2023 at $1,011 and has fallen 87.2% since, to $129 in 2025.

$1,852in general payments, 2019–2025

Across 20 payments — averaging $92.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$919
  • Boston Scientific$676
  • Cook Medical LLC$134
  • Ambu Inc.$96
  • AbbVie$27

What the payments were for

  • Travel & lodging$90049%
  • Food & beverage$95251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,852 in reported general payments places this provider in the 80th percentile of 220 gastroenterology providers in Oregon.

See all gastroenterology providers in Oregon

Medicare billing

Part B allowed, 2024
$145,850
Medicare patients
189
Services billed
5,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl63$1,126
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl25$464
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl18$336
Omeprazole18$272

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →